Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients

Kostianovsky, Alex; Charles, Pierre; Alves, Jean-François; Goulet, Michèle; Pagnoux, Christian; Le Guern, Véronique; Mouthon, Luc; Krivine, Anne; Villiger, Peter; Launay, Odile; Guillevin, Loïc; French Vasculitis Study Group, (2012). Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clinical and experimental rheumatology, 30(1 Suppl 70), S83-9. Pisa: Pacini editore

Full text not available from this repository. (Request a copy)

The 2009 pandemic A/H1N1 influenza outbreak represented a theoretical risk for patients with autoimmune diseases (AID), especially those immunosuppressed. This study was undertaken to evaluate immunogenicity and tolerance of seasonal (SFV) and A/H1N1 flu vaccines (HFV) in AID patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Villiger, Peter

ISSN:

0392-856X

Publisher:

Pacini editore

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:40

Last Modified:

17 Mar 2015 21:34

PubMed ID:

22640652

Web of Science ID:

000304499000018

URI:

https://boris.unibe.ch/id/eprint/16314 (FactScience: 223925)

Actions (login required)

Edit item Edit item
Provide Feedback